Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 62 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/23/2007


1.		Phase III Randomized, Double-Blind Study of Megestrol vs Dronabinol vs Both in Patients with Cancer-Related Anorexia and Cachexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-959255 NCI-P96-0075

Last Modified: 4/4/2008 First Published: 7/1/2000


2.		Phase III Randomized Study of Megestrol to Treat Symptoms of Ovarian Failure in Patients With Previously Treated Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				Not specified				NCI				SWOG-S9626 NCI-P00-0159, NCT00005975

Last Modified: 7/17/2006 First Published: 12/1/2000


3.		Phase III Randomized Study of the Effect of Megestrol on Weight and Quality of Life in Patients With Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				Over 18				NCI				CCCWFU-97300 CCCWFU-0009, CCCWFU-BG00-228, NCI-P00-0174, NCT00006799

Last Modified: 6/8/2007 First Published: 5/1/2001


4.		Phase III Randomized Study of Doxorubicin, Cisplatin, Paclitaxel, and Filgrastim (G-CSF) Versus Tamoxifen and Megestrol in Patients With Stage III or IV or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Not specified				NCI				GOG-0189 NCT00016341, GOG-0189

Last Modified: 11/23/2007 First Published: 3/1/2002


5.		Phase III Randomized Study of Megestrol Versus Eicosapentaenoic Acid-Enriched Nutritional Supplement Versus Both in Patients With Cancer-Related Cachexia and Anorexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				NCCTG-989255 CAN-NCIC-SC18, NCI-P02-0205, NCT00031707, SC18

Last Modified: 7/17/2006 First Published: 3/1/2002


6.		Phase III Randomized Study of Megestrol in Patients Receiving Radiotherapy for Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				Over 18				NCI				CCCWFU-98199 NCI-P02-0210, NCT00031785

Last Modified: 12/12/2007 First Published: 7/1/2002


7.		Phase III Randomized Study of Megestrol in Patients With Inoperable Hepatocellular Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				20 to 100				Other				NMRC-AHCC02 EU-20203, NCT00041275


8.		Phase III Comparison of Megestrol vs Megestrol/Tamoxifen in Patients with Inoperable Metastatic or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				EST-4882


9.		Phase III MEG vs MEG/DES vs Stilphostrol vs STZ for Previously Irradiated Hormone-Refractory Metastatic Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1600


10.		Phase III Randomized Comparison of Megestrol Acetate vs Tamoxifen for Advanced Breast Cancer in Postmenopausal Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								GUMC-8683 NCI-V83-0295

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute